Literature DB >> 10987284

Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.

D Marchetti1, J Li, R Shen.   

Abstract

Neurotrophins (NTs) modulate the brain invasion of melanoma cells and the activity of an extracellular matrix degradative enzyme, heparanase, that has been recently cloned. Heparanase degrades the heparan sulfate proteoglycans (HSPGs) and is a critical mediator of tumor metastasis and angiogenesis. Because astrocytes are among the first brain cells encountered by extravasating melanoma cells, they may play important roles in the development of brain metastases. To test this hypothesis, we used purified in vitro astrocyte cultures and found that they express heparanase transcript and functional enzyme that were up-regulated by the prototypic NT, nerve growth factor. Coincubation of astrocytes (or their conditioned medium) with brain-metastatic cells resulted in a superadditive effect on heparanase activity and up to an 8-fold increase of in vitro chemoinvasion using purified HSPGs. These observations indicate that astrocytes significantly contribute to the brain colonization of melanoma cells via heparanase-driven modalities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987284

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.

Authors:  Vy M Tran; Anna Wade; Andrew McKinney; Katharine Chen; Olle R Lindberg; Jane R Engler; Anders I Persson; Joanna J Phillips
Journal:  Mol Cancer Res       Date:  2017-08-04       Impact factor: 5.852

3.  Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia.

Authors:  Jimei Li; Jin-Ping Li; Xiao Zhang; Zhongyang Lu; Shan Ping Yu; Ling Wei
Journal:  Brain Res       Date:  2011-11-19       Impact factor: 3.252

4.  MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.

Authors:  Lixin Zhang; Peggy S Sullivan; Jerry C Goodman; Preethi H Gunaratne; Dario Marchetti
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 5.  The brain metastatic niche.

Authors:  Frank Winkler
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

6.  Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

Authors:  Mihaela Lorger; Brunhilde Felding-Habermann
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 7.  Embracing rejection: Immunologic trends in brain metastasis.

Authors:  S Harrison Farber; Vadim Tsvankin; Jessica L Narloch; Grace J Kim; April K S Salama; Gordana Vlahovic; Kimberly L Blackwell; John P Kirkpatrick; Peter E Fecci
Journal:  Oncoimmunology       Date:  2016-04-11       Impact factor: 8.110

8.  Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.

Authors:  Brunilde Gril; Diane Palmieri; Yongzhen Qian; Talha Anwar; David J Liewehr; Seth M Steinberg; Zoraida Andreu; Daniel Masana; Paloma Fernández; Patricia S Steeg; Fernando Vidal-Vanaclocha
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

9.  Heparanase mRNA expression and point mutation in hepatocellular carcinoma.

Authors:  Xiao-Peng Chen; Yin-Bib Liu; Jing Rui; Shu-You Peng; Cheng-Hong Peng; Zi-Yan Zhou; Liang-Hui Shi; Hong-Wei Shen; Bin Xu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 10.  Brain metastases in melanoma: roles of neurotrophins.

Authors:  Yvonne Denkins; Jane Reiland; Madhuchhanda Roy; Neeta D Sinnappah-Kang; Jennifer Galjour; Brian P Murry; Jason Blust; Rebecca Aucoin; Dario Marchetti
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.